Items where Author is "Mayer, J."

Article

Hehlmann, R. and Lauseker, M. and Saussele, S. and Pfirrmann, M. and Krause, S. and Kolb, H. J. and Neubauer, A. and Hossfeld, D. K. and Nerl, C. and Gratwohl, A. and Baerlocher, G. M. and Heim, D. and Bruemmendorf, T. H. and Fabarius, A. and Haferlach, C. and Schlegelberger, B. and Mueller, M. C. and Jeromin, S. and Proetel, U. and Kohlbrenner, K. and Voskanyan, A. and Rinaldetti, S. and Seifarth, W. and Spiess, B. and Balleisen, L. and Goebeler, M. C. and Haenel, M. and Ho, A. and Dengler, J. and Falge, C. and Kanz, L. and Kremers, S. and Burchert, A. and Kneba, M. and Stegelmann, F. and Koehne, C. A. and Lindemann, H. W. and Waller, C. F. and Pfreundschuh, M. and Spiekermann, K. and Berdel, W. E. and Mueller, L. and Edinger, M. and Mayer, J. and Beelen, D. W. and Bentz, M. and Link, H. and Hertenstein, B. and Fuchs, R. and Wernli, M. and Schlegel, F. and Schlag, R. and de Wit, M. and Truemper, L. and Hebart, H. and Hahn, M. and Thomalla, J. and Scheid, C. and Schafhausen, P. and Verbeek, W. and Eckart, M. J. and Gassmann, W. and Pezzutto, A. and Schenk, M. and Brossart, P. and Geer, T. and Bildat, S. and Schaefer, E. and Hochhaus, A. and Hasford, J. (2017) Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants. LEUKEMIA, 31 (11). pp. 2398-2406. ISSN 0887-6924, 1476-5551

Gratwohl, A. and Pfirrmann, M. and Zander, A. and Kroger, N. and Beelen, D. and Novotny, J. and Nerl, C. and Scheid, C. and Spiekermann, K. and Mayer, J. and Sayer, H. G. and Falge, C. and Bunjes, D. and Doehner, H. and Ganser, A. and Schmidt-Wolf, I. and Schwerdtfeger, R. and Baurmann, H. and Kuse, R. and Schmitz, N. and Wehmeier, A. and Fischer, J. Th and Ho, A. D. and Wilhelm, M. and Goebeler, M-E and Lindemann, H. W. and Bormann, M. and Hertenstein, B. and Schlimok, G. and Baerlocher, G. M. and Aul, C. and Pfreundschuh, M. and Fabian, M. and Staib, P. and Edinger, M. and Schatz, M. and Fauser, A. and Arnold, R. and Kindler, T. and Wulf, G. and Rosselet, A. and Hellmann, A. and Schaefer, E. and Pruemmer, O. and Schenk, M. and Hasford, J. and Heimpel, H. and Hossfeld, D. K. and Kolb, H-J and Buesche, G. and Haferlach, C. and Schnittger, S. and Mueller, M. C. and Reiter, A. and Berger, U. and Saussele, S. and Hochhaus, A. and Hehlmann, R. (2016) Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment. LEUKEMIA, 30 (3). pp. 562-569. ISSN 0887-6924, 1476-5551

Pfeiffer, T. and Schleuning, M. and Eder, M. and Tischer, J. and Braess, J. and Spiekermann, K. and Bunjes, D. and Greinix, H. and Bug, G. and Holler, E. and Oruzio, D. and Krejci, M. and Scheid, C. and Gerbitz, A. and Kolbe, K. and Meyer, R. G. and Arnold, R. and Christopeit, M. and Baurmann, H. and v. Harsdorf, S. and Bethge, W. A. and Dammann, E. and Rothmayer, M. and Franke, A. and Schnittger, S. and Mayer, J. and Schlimok, G. and Schwerdtfeger, R. and Ganser, A. and Kolb, H. -J. and Schmid, C. (2010) Allogeneic stem cell transplantation in acute myeloid leukaemia with normal karyotype: a risk factor analysis in 247 patients, based on molecular markers and stage at transplantation. BONE MARROW TRANSPLANTATION, 45. S10-S11. ISSN 0268-3369

Other

Dreger, P. and Boumendil, A. and Koster, L. and Scheid, C. and Passweg, J. and Veelken, H. and Cahn, Y. and Collin, M. and Wilson, K. and Bazarbachi, A. and Mayer, J. and Corradini, P. and Hunault-Berger, M. and Parody Porras, R. and Gribben, J. and Bittenbring, J. and Wolff, D. and Charbonnier, A. and Cambier, N. and Montoto, S. and Kroeger, N. and Schetelig, J. (2017) No evidence for an increased GVHD risk associated with post-transplant Idelalisib given for relapse of chronic lymphocytic leukemia or lymphoma: First results of a survey by the EBMT chronic malignancy and lymphoma working parties. NATURE PUBLISHING GROUP, LONDON.